4.5 Article

Leveraging microRNAs for cellular therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Genetics & Heredity

Prime editing for precise and highly versatile genome manipulation

Peter J. Chen et al.

Summary: In this review, the authors discuss the latest developments in prime editing systems, highlighting improvements in editing efficiency and capabilities, as well as emerging applications in research and preclinical therapeutic studies. Prime editors offer versatility, specificity, and precision in making targeted DNA changes in living cells. The review summarizes prime editing strategies, addresses their limitations, discusses recent developments to overcome these limitations, and explores potential applications and future directions.

NATURE REVIEWS GENETICS (2023)

Article Multidisciplinary Sciences

Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy

Marcel P. Trefny et al.

Summary: In this study, a human antigen-specific ex vivo model was used to explore new therapeutic options for T cell immunotherapies. The protein SNX9 was identified as a mediator of T cell exhaustion, and its knockout resulted in enhanced memory differentiation and function of adoptively transferred T cells, improving anti-tumor efficacy of chimeric antigen receptor T cells in vivo.

NATURE COMMUNICATIONS (2023)

Review Medicine, Research & Experimental

Diverse Approaches to Gene Therapy of Sickle Cell Disease

Shanna L. White et al.

Summary: Sickle cell disease is caused by a single base pair change in the sixth codon of the ss-globin chain of hemoglobin, leading to increased rigidity of red blood cells and vasoocclusive and hemolytic complications. Gene therapy with transplantation of gene-modified autologous HSCs shows promise in eliminating SCD manifestations without immune complications. Lentiviral vector-mediated gene addition and gene editing approaches have shown significant clinical improvements and provide potential therapeutic opportunities for SCD.

ANNUAL REVIEW OF MEDICINE (2023)

Article Biotechnology & Applied Microbiology

High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails

Brian R. Shy et al.

Summary: By using single-stranded DNA HDR templates with reduced toxicity and small-molecule combinations, the efficiency of CRISPR-mediated site-specific transgene insertion can be greatly enhanced. This method is applicable to various target loci, knock-in constructs, and primary human cell types, with high HDR efficiencies. Furthermore, it can be applied in pathogenic gene variant modeling, gene-replacement strategies, and nonviral chimeric antigen receptor-T cell manufacturing with improved knock-in efficiencies and yields.

NATURE BIOTECHNOLOGY (2023)

Article Multidisciplinary Sciences

Structure of the human DICER-pre-miRNA complex in a dicing state

Young-Yoon Lee et al.

Summary: It has been found that hDICER undergoes large conformational changes to attain the active state and recognizes pre-miRNAs through both sequence-independent and sequence-specific recognition of the newly identified 'GYM motif'. Cancer-associated mutations in the 5' pocket residues are identified, which impair miRNA biogenesis. This study reveals the mechanisms of hDICER and provides insights into hDICER-related diseases.

NATURE (2023)

Article Multidisciplinary Sciences

Co-opting signalling molecules enables logic-gated control of CAR T cells

Aidan M. Tousley et al.

Summary: Researchers have developed a new CAR T cell platform called LINK CAR, which replaces traditional CD3 zeta domains with intracellular proximal T cell signalling molecules. LINK CAR can activate T cells and eradicate tumors in vivo while bypassing certain upstream signalling proteins, showing superior efficacy and prevention of off-tumor toxicity compared to other systems. This study expands the range of molecules that can be targeted with CAR T cells, enabling their application in solid tumors, autoimmune diseases, and fibrosis, and also highlights the potential of repurposing cellular signaling machinery for cellular engineering.

NATURE (2023)

Article Multidisciplinary Sciences

Sequence determinant of small RNA production by DICER

Young-Yoon Lee et al.

Summary: RNA silencing depends on Dicer's specific and efficient processing of double-stranded RNA to produce microRNAs and small interfering RNAs. A new study found evidence for an additional sequence-dependent determinant, called the "GYM motif", which promotes processing at a specific position and enhances RNA interference. The C-terminal double-stranded RNA-binding domain of DICER recognizes the GYM motif, and alterations in this domain affect miRNA processing and cleavage sites.

NATURE (2023)

Article Multidisciplinary Sciences

CAR immune cells: design principles, resistance and the next generation

Louai Labanieh et al.

Summary: The development of next-generation CAR immune cell technologies has greatly improved the efficacy, safety, and accessibility of CAR therapies. Multispecific, logic-gated, and regulatable CARs show promise in overcoming resistance and increasing safety. Stealth, virus-free, and in vivo gene delivery platforms may reduce costs and improve access to cell therapies. The success of CAR T cells in liquid cancers is driving the development of more sophisticated immune cell therapies for solid cancers and non-malignant diseases in the future.

NATURE (2023)

Article Oncology

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas

Brian J. Sworder et al.

Summary: This study investigates the resistance of anti-CD19 chimeric antigen receptor (CAR19) T cells in relapsed/refractory large B-cell lymphoma (r/rLBCL) patients. By analyzing longitudinal samples from two independent cohorts, it identifies multiple gene alterations associated with resistance, such as B cell identity genes (PAX5 and IRF8), immune checkpoint genes (CD274), and genes affecting the tumor microenvironment (TMEM30A). It also reveals that somatic tumor alterations affect CAR19 therapy at various levels, including CAR19 T cell expansion, persistence, and tumor microenvironment. These findings have implications for improving CAR T cells and personalized therapeutic approaches.

CANCER CELL (2023)

Article Multidisciplinary Sciences

CAR T therapy beyond cancer: the evolution of a living drug

Daniel J. Baker et al.

Summary: Engineering CAR T cells to target and eliminate tumour cells has proven successful in curing untreatable haematologic cancers, sparking interest in applying this therapy to noncancerous diseases. Clinical and preclinical studies suggest CAR T therapy could be effective in addressing autoimmunity, chronic infections, cardiac fibrosis, senescence-associated diseases, and more. This review explores the rationale behind CAR T therapy, current challenges in oncology, preliminary reports in noncancerous diseases, and emerging technologies. The article discusses the potential applications and highlights concerns about specificity and safety.

NATURE (2023)

Article Multidisciplinary Sciences

In vivo hematopoietic stem cell modification by mRNA delivery

Laura Breda et al.

Summary: This study developed a nanoparticle system that can target hematopoietic stem cells in vivo and achieved correction of diseased cells through mRNA delivery. Furthermore, this system enables non-genotoxic conditioning for stem cells, providing a new approach for HSCT.

SCIENCE (2023)

Article Multidisciplinary Sciences

CRISPR activation and interference screens decode stimulation responses in primary human T cells

Ralf Schmidt et al.

Summary: This study conducted gene screening using CRISPR technology in primary human T cells, identifying gene networks that regulate the production of interleukin-2 and interferon-gamma. It revealed reshaped cytokine responses and the mechanisms of T cell activation, providing new insights for designing immunotherapies.

SCIENCE (2022)

Article Multidisciplinary Sciences

CAR T cells produced in vivo to treat cardiac injury

Joel G. Rurik et al.

Summary: This study developed a therapeutic approach to generate antifibrotic CAR T cells in vivo by delivering modified mRNA in T cell-targeted nanoparticles. The efficacy of these in vivo-reprogrammed CAR T cells was evaluated in a mouse model of heart failure.

SCIENCE (2022)

Article Biochemistry & Molecular Biology

Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells

Attya Omer-Javed et al.

Summary: Hematopoietic stem/progenitor cell gene therapy has been successful in treating genetic diseases. Mobilizers provide an opportunity for exogenous cells to efficiently replace depleted bone marrow through competition. This competitive advantage is achieved by rescuing the detrimental effects of mobilization on hematopoietic stem/progenitor cells during ex vivo culture, and can be further enhanced by transient overexpression of engraftment effectors.
Article Immunology

CRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical Application

Bettina E. Bernard et al.

Summary: Engineering human T cells for cancer, viral infections, and autoimmune diseases has been a dream for many immunologists and hematologists. The discovery and adaptation of CRISPR/Cas9 to human T cells have revolutionized the field, making T cell engineering more accessible and accelerating the development of engineered adoptive T cell therapies.

IMMUNOLOGY LETTERS (2022)

Review Biochemistry & Molecular Biology

Engineered cellular immunotherapies in cancer and beyond

Amanda V. Finck et al.

Summary: This Review discusses the goals and challenges of cellular immunotherapy in cancer and outlines strategies to overcome these challenges, highlighting the importance of this field in the treatment of other diseases.

NATURE MEDICINE (2022)

Editorial Material Biotechnology & Applied Microbiology

Landscape of cancer cell therapies: trends and real-world data

Ana Rosa Saez-Ibanez et al.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Multidisciplinary Sciences

MicroRNA-29a attenuates CD8 T cell exhaustion and induces memory-like CD8 T cells during chronic infection

Erietta Stelekati et al.

Summary: This study identifies miR-29a as a key regulator of exhausted CD8 T cells (TEX) during chronic viral infection. It shows that miR-29a improves CD8 T cell responses, inhibits exhaustion-driving transcriptional pathways, and regulates ribosomal biogenesis. As a result, miR-29a promotes a memory-like CD8 T cell differentiation state during chronic infection.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Review Genetics & Heredity

Emerging concepts of miRNA therapeutics: from cells to clinic

Caroline Diener et al.

Summary: In this review, the main challenges and strategies for the therapeutic application of miRNAs are discussed, with particular emphasis on approaches that have already been studied clinically.

TRENDS IN GENETICS (2022)

Review Biochemistry & Molecular Biology

The landscape of mRNA nanomedicine

Xiangang Huang et al.

Summary: mRNA is an emerging therapeutic agent with great potential for revolutionizing life science and medical research. Recent progress in mRNA engineering and delivery has addressed the challenges related to stability, immunogenicity, and in vivo delivery. The success of mRNA vaccines against COVID-19 has transformed the field and opened up possibilities for treating other diseases.

NATURE MEDICINE (2022)

Article Medicine, General & Internal

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan et al.

Summary: This phase 3 trial demonstrates that patients with advanced melanoma who received TIL therapy had significantly longer progression-free survival compared to those who received ipilimumab.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Oncology

Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence

Julia A. Belk et al.

Summary: This study demonstrates that modulation of chromatin remodeling complexes improves the persistence of T cells in tumors and enhances antitumor immunity, providing important insights into the genetic regulators of T cell exhaustion.

CANCER CELL (2022)

Article Multidisciplinary Sciences

Multidimensional control of therapeutic human cell function with synthetic gene circuits

Hui-Shan Li et al.

Summary: Researchers have developed a synthetic zinc finger transcription regulator platform that allows precise control over therapeutic genes in primary T cells, expanding the capabilities of gene and cell-based therapies.

SCIENCE (2022)

Article Multidisciplinary Sciences

speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing

Rocio Castellanos-Rueda et al.

Summary: This study presents a new method called speedingCARs for engineering CAR T cells, which utilizes signaling domain shuffling and pooled functional screening to generate CAR variants with tumor killing properties and distinct T cell phenotypes. The results support the expansion of CAR signaling domain combination space and the potential application of speedingCARs in therapeutic development.

NATURE COMMUNICATIONS (2022)

Article Immunology

Selective miRNA inhibition in CD8+ cytotoxic T lymphocytes enhances HIV-1 specific cytotoxic responses

Nadia Madrid-Elena et al.

Summary: This study demonstrates that modulation of miRNA expression in T cells enhances specific cytotoxic immune responses to HIV, providing a new approach for achieving HIV remission.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Forced expression of the non-coding RNA miR-17∼92 restores activation and function in CD28- deficient CD4+ T cells

Marianne Dolz et al.

Summary: CD28 provides the prototypical costimulatory signal for T cell activation. miR-17 similar to 92, induced by T cell receptor stimulation and enhanced by CD28 costimulation, acts as a central mediator for T cell activation by dampening negative regulators.

ISCIENCE (2022)

Article Multidisciplinary Sciences

RASA2 ablation in T cells boosts antigen sensitivity and long-term function

Julia Carnevale et al.

Summary: This study identifies RASA2 as a potential target gene that can enhance the efficacy of T cell therapies for cancer treatment. Ablation of RASA2 increases the activation and cytolytic activity of T cells, leading to improved cancer cell killing. Furthermore, RASA2-deficient CAR T cells have a competitive advantage in the bone marrow and extended the survival of mice in preclinical models. These findings highlight the importance of targeting RASA2 in enhancing T cell therapies for cancer treatment.

NATURE (2022)

Article Medicine, General & Internal

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

H. Frangoul et al.

Summary: Research utilizing CRISPR-Cas9 technology for gene editing in patients with TDT and SCD showed high levels of edited alleles in bone marrow and blood, leading to partial or complete elimination of symptoms.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

T cell circuits that sense antigen density with an ultrasensitive threshold

Rogelio A. Hernandez-Lopez et al.

Summary: The study engineered a two-step positive-feedback circuit that enables human cytotoxic T cells to discriminate targets based on a sigmoidal antigen-density threshold. This circuit involves a low-affinity synthetic Notch receptor controlling the expression of a high-affinity CAR, leading to sharp discrimination between cancer cells and normal cells based on antigen density.

SCIENCE (2021)

Review Oncology

The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead

Adam Nelson et al.

Summary: NKT cells are a specialized subset of lipid-reactive T lymphocytes that play direct and indirect roles in immunosurveillance and anti-tumor immunity. Preclinical studies have shown that NKT cell activation via delivery of exogenous glycolipids elicits a significant anti-tumor immune response. This review also examines challenges and future directions for improving the therapy.

CANCERS (2021)

Review Immunology

CAR T cells: Building on the CD19 paradigm

Anat Globerson-Levin et al.

Summary: Therapeutic use of CARs targeting CD19 has led to significant success in treating B-cell malignancies, sparking interest in T-cell engineering and cancer immunotherapy. Advances in CAR design, cell manufacturing, and genome editing hold promise for safer and more effective genetically instructed immunity, with potential applications in a wide range of diseases in the future.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges

Mehrdad Hefazi et al.

Summary: This review provides the latest preclinical and clinical data on Treg cell therapy in the context of GVHD, highlighting the importance of T cell therapy in preventing and treating GVHD, and discussing future research directions and challenges.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, General & Internal

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Julian D. Gillmore et al.

Summary: The gene-editing therapeutic agent NTLA-2001 effectively reduced serum TTR protein concentrations in patients with ATTR amyloidosis, showing potential safety and pharmacodynamic effects in clinical studies.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cell Biology

Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering

Jennifer R. Hamilton et al.

Summary: A new strategy has been developed in this study, which uses engineered lentiviral particles to introduce Cas9 RNPs and a CAR transgene into human T cells ex vivo, allowing targeting of specific cell types within a mixed population. This approach provides a method for genetic modification of immune cells without the need for electroporation.

CELL REPORTS (2021)

Review Biochemistry & Molecular Biology

Role of miRNAs and lncRNAs in hematopoietic stem cell differentiation

Soudeh Ghafouri-Fard et al.

Summary: Non-coding RNAs play diverse roles in the differentiation of hematopoietic cells, with long ncRNAs and miRNAs affecting transcription factors levels and contributing to the differentiation process. miRNAs such as miR-222, miR-10a, and lncRNAs like PU.1-AS are involved in hematopoietic stem cell differentiation, with manipulation of their expression having functional significance in cancer treatment and cell therapy. This paper provides a brief summary of the roles of miRNAs and lncRNAs in regulating hematopoietic stem cells.

NON-CODING RNA RESEARCH (2021)

Article Biotechnology & Applied Microbiology

A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy

Greta Giordano-Attianese et al.

NATURE BIOTECHNOLOGY (2020)

Article Multidisciplinary Sciences

CRISPR-engineered T cells in patients with refractory cancer

Edward A. Stadtmauer et al.

SCIENCE (2020)

Article Biochemistry & Molecular Biology

Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies

Theodore L. Roth et al.

Review Oncology

Gene modification strategies for next-generation CAR T cells against solid cancers

Yonggui Tian et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Article Multidisciplinary Sciences

De novo design of protein logic gates

Zibo Chen et al.

SCIENCE (2020)

Review Biotechnology & Applied Microbiology

Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors

Andrew V. Anzalone et al.

NATURE BIOTECHNOLOGY (2020)

Article Immunology

A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy

Shannon K. Oda et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Multidisciplinary Sciences

Precise T cell recognition programs designed by transcriptionally linking multiple receptors

Jasper Z. Williams et al.

SCIENCE (2020)

Review Immunology

T-reg cell-based therapies: challenges and perspectives

Caroline Raffin et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Immunology

HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells

Harald Hartweger et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Article Multidisciplinary Sciences

Modular and tunable biological feedback control using a de novo protein switch

Andrew H. Ng et al.

NATURE (2019)

Article Multidisciplinary Sciences

De novo design of bioactive protein switches

Robert A. Langan et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Aude G. Chapuis et al.

NATURE MEDICINE (2019)

Article Immunology

B cells engineered to express pathogen-specific antibodies protect against infection

Howell F. Moffett et al.

SCIENCE IMMUNOLOGY (2019)

Review Hematology

Allogeneic hematopoietic cell transplantation; the current renaissance

Edward A. Copelan et al.

BLOOD REVIEWS (2019)

Article Multidisciplinary Sciences

c-Jun overexpression in CAR T cells induces exhaustion resistance

Rachel C. Lynn et al.

NATURE (2019)

Review Biochemistry & Molecular Biology

Metazoan MicroRNAs

David P. Bartel

Article Biotechnology & Applied Microbiology

Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells

King L. Hung et al.

MOLECULAR THERAPY (2018)

Article Biotechnology & Applied Microbiology

IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor

Keishi Adachi et al.

NATURE BIOTECHNOLOGY (2018)

Article Medicine, Research & Experimental

In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome

Anett Pfeiffer et al.

EMBO MOLECULAR MEDICINE (2018)

Article Multidisciplinary Sciences

Reprogramming human T cell function and specificity with non-viral genome targeting

Theodore L. Roth et al.

NATURE (2018)

Article Immunology

Emerging Cellular Therapies for Cancer

Sonia Guedan et al.

Annual Review of Immunology (2018)

Review Cell Biology

Dendritic cell-based immunotherapy

Rachel L. Sabado et al.

CELL RESEARCH (2017)

Article Multidisciplinary Sciences

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

Justin Eyquem et al.

NATURE (2017)

Article Nanoscience & Nanotechnology

In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers

Tyrel T. Smith et al.

NATURE NANOTECHNOLOGY (2017)

Article Cell Biology

miR-150-Mediated Foxo1 Regulation Programs CD8+ T Cell Differentiation

Young Ho Ban et al.

CELL REPORTS (2017)

Article Immunology

The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection

Howell F. Moffett et al.

NATURE IMMUNOLOGY (2017)

Review Immunology

MicroRNAs as regulatory elements in immune system logic

Arnav Mehta et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Cell & Tissue Engineering

MicroRNAs in Control of Stem Cells in Normal and Malignant Hematopoiesis

Christine Roden et al.

CURRENT STEM CELL REPORTS (2016)

Article Biochemistry & Molecular Biology

Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity

Akemi Kosaka et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Multidisciplinary Sciences

Remote control of therapeutic T cells through a small molecule-gated chimeric receptor

Chia-Yung Wu et al.

SCIENCE (2015)

Article Cell Biology

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

Jeffrey A. Bluestone et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Multidisciplinary Sciences

miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines

Yun Ji et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Immunology

MicroRNAs in hematopoietic development

Sara Montagner et al.

BMC IMMUNOLOGY (2014)

Article Biochemistry & Molecular Biology

Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity

F. Ann Ran et al.

Review Immunology

MicroRNA regulation of T-cell differentiation and function

Lukas T. Jeker et al.

IMMUNOLOGICAL REVIEWS (2013)

Article Multidisciplinary Sciences

MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation

Sara Trifari et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Immunology

MicroRNA-mediated regulation of T helper cell differentiation and plasticity

Dirk Baumjohann et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Article Hematology

Regulation of acute graft-versus-host disease by microRNA-155

Parvathi Ranganathan et al.

Review Oncology

The MicroRNA-17-92 Family of MicroRNA Clusters in Development and Disease

Carla P. Concepcion et al.

CANCER JOURNAL (2012)

Article Immunology

miR-146a controls the resolution of T cell responses in mice

Lili Yang et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Review Biochemistry & Molecular Biology

The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC

Marc R. Fabian et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)

Article Multidisciplinary Sciences

Dicer recognizes the 5′ end of RNA for efficient and accurate processing

Jong-Eun Park et al.

NATURE (2011)

Article Medicine, Research & Experimental

Abrogating Cbl-b in effector CD8+ T cells improves the efficacy of adoptive therapy of leukemia in mice

Ingunn M. Stromnes et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Biochemistry & Molecular Biology

Hsc70/Hsp90 Chaperone Machinery Mediates ATP-Dependent RISC Loading of Small RNA Duplexes

Shintaro Iwasaki et al.

MOLECULAR CELL (2010)

Article Multidisciplinary Sciences

Mammalian microRNAs predominantly act to decrease target mRNA levels

Huili Guo et al.

NATURE (2010)

Article Cell Biology

miR-19 is a key oncogenic component of mir-17-92

Virginie Olive et al.

GENES & DEVELOPMENT (2009)

Article Multidisciplinary Sciences

Requirement of bic/microRNA-155 for normal immune function

Antony Rodriguez et al.

SCIENCE (2007)

Article Multidisciplinary Sciences

Regulation of the germinal center response by microRNA-155

To-Ha Thai et al.

SCIENCE (2007)

Article Biochemistry & Molecular Biology

RNA polymerase III transcribes human microRNAs

Glen M. Borchert et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)

Article Multidisciplinary Sciences

Cancer regression in patients after transfer of genetically engineered lymphocytes

Richard A. Morgan et al.

SCIENCE (2006)

Article Biochemistry & Molecular Biology

miRBase: microRNA sequences, targets and gene nomenclature

Sam Griffiths-Jones et al.

NUCLEIC ACIDS RESEARCH (2006)

Article Multidisciplinary Sciences

A microRNA polycistron as a potential human oncogene

L He et al.

NATURE (2005)

Article Biochemistry & Molecular Biology

MicroRNA genes are transcribed by RNA polymerase II

Y Lee et al.

EMBO JOURNAL (2004)

Article Biochemistry & Molecular Biology

A uniform system for microRNA annotation

V Ambros et al.